Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners.
Fine Michèle DietrichAndreas ZellerKurt E HersbergerIsabelle ArnetPublished in: BMJ open quality (2024)
AMoPac was rated as useful for identifying and excluding non-adherence in patients with hypertension and was highly accepted among patients. Including adherence data in clinical decision-making could contribute to optimising patient care.
Keyphrases
- blood pressure
- end stage renal disease
- decision making
- newly diagnosed
- chronic kidney disease
- glycemic control
- peritoneal dialysis
- physical activity
- pulmonary embolism
- prognostic factors
- mental health
- electronic health record
- social support
- type diabetes
- adipose tissue
- big data
- metabolic syndrome
- patient reported outcomes
- machine learning
- patient reported
- deep learning